Welcome remarks from HBA Europe
1:00 - 1:15 pm
Kathrin Schoenborn-Sobolewski, VP, head of integrated planning, analytics & partnering, Merck and chair, HBA Europe
Kathrin’s team leads the global integrated R&D business operations approach within Merck’s biopharma business. Kathrin is a pharmacist and holds a PhD from Bonn University, Germany. After several years in public pharmacies and with Sandoz, she joined Merck in 1995. Overall, Kathrin has more than 25 years of global healthcare experience in project leadership, business development, strategic planning and innovation, global clinical operations and R&D operations. She is recognized as an inspiring leader with a proven track record of success in building and leading high performing teams, designing and implementing change and driving delivery and results. Kathrin is very passionate about diversity in business, since 2010 as an active volunteer with, and since 2018 as regional council chair of HBA Europe. In 2015, she was honored as an HBA Luminary for Merck as a role model, active mentor and sponsor to others and an example of transformational leadership.